Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors.
Kazushige WakudaMichitoshi YabeHiroaki KodamaNaoya NishiokaTaichi MiyawakiEriko MiyawakiNobuaki MamesayaHaruki KobayashiShota OmoriAkira OnoHirotsugu KenmotsuTateaki NaitoHaruyasu MurakamiTetsuo ShimizuYasuhiro GonToshiaki TakahashiPublished in: Japanese journal of clinical oncology (2021)
We found that the long-term outcomes in ED-SCLC patients treated without ICIs were poor. Prior to the approval of ICI treatment for ED-SCLC, there was no improvement in the OS for ~20 years.